When a “Stable” MRI Isn’t a Stable Patient
Inside a Real Cognitive Case Collaboration From the TruNeura Mastermind
This week inside the TruNeura Mastermind, we walked through a case that perfectly illustrates the diagnostic gap in cognitive care.
A 72 year old woman with mild cognitive impairment.
Documented cerebral amyloid angiopathy.
White matter changes.
Microhemorrhages.
Anxiety.
Recurrent viral susceptibility.
Metabolic dysfunction that looks “fine” on conventional labs.
On paper, she is stable.
In reality, she is physiologically fragile.
And that distinction is exactly where advanced cognitive care lives.
What Made This Case Different
Jennifer Belew, PharmD, brought this case forward. With 17 years of clinical pharmacy experience and deep roots in hormone and functional care, Jen is now integrating brain health strategies into her executive women’s practice.
This case was personal.
Family history.
Genetic risk.
Progression despite conventional management.
She had already implemented diet shifts, lifestyle interventions, low dose naltrexone, hormone support, and medication adjustments. There had been measurable stabilization. Even subtle improvements.
But the MRI still showed progression of white matter disease.
The question was not, “What protocol do we try next?”
The question was, “What are we still missing?”
The Layers We Explored
Inside the session, Kristine Burke, M.D. guided a systems level analysis that moved far beyond surface interpretation.
The group examined:
The energetic demands of amyloid clearance
The role of mitochondrial genetics in ATP production
Vascular inflammation versus lipid numbers
Immune exhaustion patterns hidden beneath normal ranges
Mycotoxin driven anxiety and neuroinflammation
Hormonal entropy and depletion
The tightrope of anticoagulation in the setting of microhemorrhages
At one point, someone said what we were all thinking.
“All her conventional labs look great.”
And that was exactly the point.
Everything that mattered was hiding in the patterns.
The Real Value Was Not the Answers
Yes, there were specific next steps identified.
Advanced vascular markers.
Immune sub fractionation.
SIRs pathway clarification.
Sleep architecture restoration.
Environmental mold investigation.
Cognitive biomarker tracking.
But the most powerful part of the session was not a checklist.
It was watching experts think in real time.
You cannot get that from a lecture.
You cannot get that from a protocol PDF.
You cannot get that from social media clips.
You get it from collaborative case review with clinicians who have done this for decades.
Why This Matters for Your Practice
Cases like this are becoming more common.
Patients with mixed pathology.
Normal appearing standard labs.
Complex immune and vascular interplay.
Families desperate for clarity.
Without structured collaboration, these cases become overwhelming.
With the right system and the right minds in the room, they become solvable.
That is what the TruNeura Mastermind is building.
Not just education.
A clinical hive mind.
Every case strengthens collective pattern recognition.
Every discussion sharpens decision making.
Every practitioner levels up.
And the software ensures nothing is lost in the process.
